Alexandria Real Estate Equities I.../ US0152711091 /
5/26/2023 9:59:56 PM | Chg. +0.55 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
111.79USD | +0.49% | 44,157 Turnover: 4.93 mill. |
-Bid Size: - | -Ask Size: - | 19.34 bill.USD | 4.22% | 35.15 |
GlobeNewswire
2/23/2022
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Th...
GlobeNewswire
10/21/2021
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Ein...
GlobeNewswire
9/21/2021
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footpr...
GlobeNewswire
5/13/2021
TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
3/29/2021
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
GlobeNewswire
2/24/2021
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
GlobeNewswire
8/12/2020
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second ...
GlobeNewswire
11/14/2019
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
GlobeNewswire
8/7/2019
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling...
GlobeNewswire
4/10/2019
Research Report Identifies Ringcentral, The Walt Disney, MDC Partners, Alexandria Real Estate Equiti...
GlobeNewswire
2/20/2019
Consolidated Research: 2019 Summary Expectations for Delta Air Lines, Alexandria Real Estate Equitie...
GlobeNewswire
2/19/2019
CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement